Piribo: The worlds most widely read reference on emerging pharma/biotech R&D trends worldwide
July 31, 2006 (PRLEAP.COM) Health News
Now industry's most widely read reference on emerging pharma/biotech R&D trends worldwide, PAREXEL's Pharmaceutical R&D Statistical Sourcebook 2006/2007 features hundreds of all-new, real-world studies, analyses, articles, and data sets providing fresh insights into the developments reshaping pharma R&D and the industry itself.Supported by thousands of graphs, illustrations, and analyses, PAREXEL'S Pharmaceutical R&D Statistical Sourcebook 2006/2007 provides the latest intelligence on every aspect of pharmaceutical development—from product discovery to R&D performance and productivity to time-to-market trends.
An invaluable resource for executives and managers working within or with the pharma and biotech industries, this 2006/2007 compendium puts real-world data sets at your fingertips for presentations, reports, business development efforts, meetings, and critical decision-making analyses:
New R&D Spending Trends (U.S. and Global)
International Statistics on Drug Development Output Industry-wide and Company-by-Company
Emerging Data on the Worldwide and Company-specific R&D Pipelines and Product Launch Trends
New Analyses on Drug Development Costs/Development Cycle Times/Attrition Rates
Drug Approval Statistics Compiled from FDA, EMEA and other Key Regulatory Agencies
International R&D Data from Key Global Markets
“Parexel's Pharmaceutical R&D Statistical Sourcebook 2006/2007” is priced at £235 and is available in hard copy format from Piribo. For more information go to: http://www.piribo.com/search/results.html?k=+BAR019&x=2&y=13
Piribo Product Code: BAR019
About Piribo.
Piribo is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,500 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.